ENDPOINTS

Sionna inks $191M IPO for cystic fibrosis pipeline as Aardvark eyes $89M for its own listing

Cystic fibrosis biotech Sionna Therapeutics will raise $191 million in its upsized Nasdaq debut on Friday, and metabolic disease biotech Aardvark Therapeutics outlined plans for a potential $89 million IPO. ...

Feb 9, 2025 - 21:50
 0
Sionna inks $191M IPO for cystic fibrosis pipeline as Aardvark eyes $89M for its own listing
Cystic fibrosis biotech Sionna Therapeutics will raise $191 million in its upsized Nasdaq debut on Friday, and metabolic disease biotech Aardvark Therapeutics outlined plans for a potential $89 million IPO. ...
Read More

Tags:

Previous Article

Longtime Sandoz exec announces retirement; Lilly appoints head of India

Next Article

Acelyrin and Alumis to merge in deal combining cash, assets

Related Posts

Vertex operations chief Stuart Arbuckle to retire

Vertex operations chief Stuart Arbuckle to retire

Feb 11, 2025  0

J&J, Intra-Cellular quickly sealed $14B deal as three others passed on buying the neuro drugmaker

J&J, Intra-Cellular quickly sealed $14B deal as three o...

Feb 9, 2025  0

Q4 earnings updates; Biogen details revised research strategy; RFK Jr. advances out of Senate committee; and more

Q4 earnings updates; Biogen details revised research st...

Feb 9, 2025  0